As common molecular subtypes, EBV-positive GC and MSI-H GC were both associated with enhanced ORR and PD-L1/PD-1 antibody efficacy, with EBV-positive GC having close to 100% ORR (28). The gene discussed is CD274; the disease is gastric cancer.